Aurinia
Aurinia focuses on the development and commercialization of novel drug products for the treatment of lupus nephritis.
Business Model:
Revenue: $129M
Employees: 201-500
Industries / Tags:
Detailed Aurinia Information
Geographic Data
Address: 4464 Markham Street
City: Victoria
State: british columbia
Zip: V8Z 7X8
Country: CA
Financial Info
Stage:
post ipo equity
Raised Last:
$200M
Raised Total:$77M
Social
Metrics
1,903,666Website Global Rank
11,508Website Monthly Traffic
Twitter Followers
Description
Aurinia focuses on the development and commercialization of novel drug products for the treatment of lupus nephritis.
Contact Phone:
Contact Email:
Aurinia went public on 9/2/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/2/2014
Ticker Symbol:
AUPH
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 2/2013 | Isotechnika Pharma |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
